Hold onto your hats, baseball fans, because there’s a potential mega-trade brewing that could shake the MLB landscape more than any Skubal deal ever could. But here’s where it gets controversial: the Los Angeles Dodgers might not need to chase Tarik Skubal after all. While Skubal’s name has been tossed around in trade rumors—especially since he’s in the final year of his $32 million contract—he’s not the most tantalizing upgrade for the Dodgers. Enter Sandy Alcantara, the former Cy Young winner who’s finally starting to resemble his old self after a grueling injury rehab. And this is the part most people miss: Alcantara’s trade value is at an all-time low, making him a potential bargain for a team like the Dodgers.
Alcantara’s journey has been nothing short of a rollercoaster. After undergoing Tommy John surgery in 2024, he struggled mightily in 2025, posting a 5.36 ERA. But here’s the kicker: his performance improved as the season progressed, hinting that he might be on the cusp of a comeback. If the Dodgers want to buy low on one of baseball’s most dominant pitchers, now is the time. But here’s the controversy: is Alcantara’s injury history too risky, or is this the perfect opportunity for a high-reward move?
Alcantara himself seems confident. At Marlins media day, he admitted, ‘Coming back from TJ, you’re not going to do great since the first day. You’ve got to be step by step.’ He acknowledged the mental toll of negative chatter but remains focused on proving himself again. Yet, his stats since 2022—when he was the NL Cy Young winner—have been a cause for concern. From a 2.28 ERA in 2022 to a 5.36 ERA in 2025, the numbers tell a story of decline. But is that decline permanent, or is there untapped potential waiting to resurface?
The Dodgers, known for their aggressive moves, could be the perfect team to bet on Alcantara’s revival. Their rotation is already deep, with names like Yoshinobu Yamamoto and Blake Snell leading the charge. But adding Alcantara—on an affordable contract with a club option for 2027—could elevate them from good to great. Here’s the thought-provoking question: Would you rather see the Dodgers overpay for a proven ace at the deadline or take a calculated risk on Alcantara now?
For the Marlins, trading Alcantara feels like a no-brainer. They’ve already missed their window to maximize his value, and waiting until the deadline is a gamble. A package centered around a proven MLB-level prospect like Sheehan and a top-10 Dodgers prospect could be too good to pass up. But would the Marlins settle for less, or will they hold out for a bigger return?
So, what do you think? Is Alcantara worth the risk for the Dodgers, or should they steer clear of his injury history? And for the Marlins, is this the right time to cash in, or should they wait and hope for a bounce-back season? Let’s hear your thoughts in the comments—this debate is far from over.
